JT001 (sodium)
JT001 (NLRP3-IN-19) sodium is a potent, specific and orally active inhibitor of NLRP3. JT001 sodium can inhibit NLRP3 inflammasome assembly, resulting in the inhibition of cytokine release and the prevention of pyroptosis. JT001 sodium can be used for the research of nonalcoholic steatohepatitis and liver fibrosis[1].
Product Specifications
Product Name Alternative
NLRP3-IN-19 (sodium)
UNSPSC
12352005
Target
NOD-like Receptor (NLR)
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/jt001-sodium.html
Purity
98.39
Solubility
H2O : 50 mg/mL (ultrasonic)
Smiles
O=C(NS(=O)(C1=C2OCCCN2N=C1)=O)NC3=C4CCCC4=CC5=C3CCC5.[Na]
Molecular Formula
C19H22N4NaO4S
Molecular Weight
425.46
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-156034A/JT001-sodium-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-156034A/JT001-sodium-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
Phase 3
Isoform
NLRP3
CAS Number
[2238820-09-0]
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Dehalococcoides sp. Protein translocase subunit SecD (secD)
Recombinant Dehalococcoides sp. Protein translocase subunit SecD (secD)
Recombinant Dehalococcoides sp. Protein translocase subunit SecD (secD)
EGFR (Epidermal Growth Factor Receptor) (F4), Biotin conjugate, 0.1mg/mL